Cell Death and Disease (Jul 2021)

Growth differentiation factor 11 attenuates cardiac ischemia reperfusion injury via enhancing mitochondrial biogenesis and telomerase activity

  • Lin Chen,
  • Guangjin Luo,
  • Yameng Liu,
  • Hairuo Lin,
  • Cankun Zheng,
  • Dongxiao Xie,
  • Yingqi Zhu,
  • Lu Chen,
  • Xiaoxia Huang,
  • Donghong Hu,
  • Jiahe Xie,
  • Zhenhuan Chen,
  • Wangjun Liao,
  • Jianping Bin,
  • Qiancheng Wang,
  • Yulin Liao

DOI
https://doi.org/10.1038/s41419-021-03954-8
Journal volume & issue
Vol. 12, no. 7
pp. 1 – 14

Abstract

Read online

Abstract It has been reported that growth differentiation factor 11 (GDF11) protects against myocardial ischemia/reperfusion (IR) injury, but the underlying mechanisms have not been fully clarified. Considering that GDF11 plays a role in the aging/rejuvenation process and that aging is associated with telomere shortening and cardiac dysfunction, we hypothesized that GDF11 might protect against IR injury by activating telomerase. Human plasma GDF11 levels were significantly lower in acute coronary syndrome patients than in chronic coronary syndrome patients. IR mice with myocardial overexpression GDF11 (oe-GDF11) exhibited a significantly smaller myocardial infarct size, less cardiac remodeling and dysfunction, fewer apoptotic cardiomyocytes, higher telomerase activity, longer telomeres, and higher ATP generation than IR mice treated with an adenovirus carrying a negative control plasmid. Furthermore, mitochondrial biogenesis-related proteins and some antiapoptotic proteins were significantly upregulated by oe-GDF11. These cardioprotective effects of oe-GDF11 were significantly antagonized by BIBR1532, a specific telomerase inhibitor. Similar effects of oe-GDF11 on apoptosis and mitochondrial energy biogenesis were observed in cultured neonatal rat cardiomyocytes, whereas GDF11 silencing elicited the opposite effects to oe-GDF11 in mice. We concluded that telomerase activation by GDF11 contributes to the alleviation of myocardial IR injury through enhancing mitochondrial biogenesis and suppressing cardiomyocyte apoptosis.